SALT POINT STRATEGIES

Lobbying for VERTEX PHARMACEUTICALS · Biopharmaceutical company.

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 18, 2026

Income

$40,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Pharmacy

Non-opioid pain relief and drug pipeline issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.